Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Christopher J. Lahart"'
Autor:
Michael J. Keherly, Roderic H. Fabian, Vicki M. Soukup, Kimberly W. Schuenke, Christopher J. Lahart, Benjamin B. Gelman, Frances J. Richey, Charles E. Holzer
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 39:422-425
Expansion of the lysosomal apparatus occurs in subcortical white matter in brains from persons with AIDS. This study examined whether HIV-associated subcortical dementia (HAD) is significantly related to this lysosomal anomaly. Brain cortex and adjac
Autor:
Charles E. Holzer, Michael J. Keherly, Kimberly W. Schuenke, Benjamin B. Gelman, Christopher J. Lahart, Frances J. Richey, Vicki M. Soukup
Publikováno v:
Journal of Neuroimmunology. 157:111-119
A gene expression profile of the human brain cortex was performed in people with HIV-1-associated dementia (HAD) using Affymetrix HG-U133 chips. Messenger RNA transcripts in middle frontal gyrus from subjects with HAD or milder neurocognitive dysfunc
Autor:
Jennifer L. Minihan, Prasuna Sajja, Fehmida Visnegarwala, Mario Maldonado, Oliver Ong, Ashok Balasubramanyam, Christopher J. Lahart, A. Clinton White, Mirza Qasim Hasan, Maria C. Rodriguez-Barradas
Publikováno v:
Journal of Infection. 49:283-290
Objectives. Dyslipidemia associated with antiretroviral therapy is a common clinical problem among HIV-infected patients. Considering that the challenge of adherence to drugs (both antiretroviral and lipid lowering) may be substantial in routine HIV
Autor:
William J. Burman, Fred M. Gordin, Beverly Metchock, Lorna Bozeman, Richard E. Chaisson, Debra Benator, C. Robert Horsburgh, Stephen E. Weis, Andrew Vernon, Mondira Bhattacharya, Cheng Wang Yong, Constance Pachucki, Christopher J. Lahart, James Horton, Awal Khan, Antonino Catanzaro, M. Elsa Villarino, Llewellyn Stanton, Marc H Weiner
Publikováno v:
The Lancet. 360:528-534
Background Rifapentine has a long half-life in serum, which suggests a possible treatment once a week for tuberculosis. We aimed to compare rifapentine and isoniazid once a week with rifampicin and isoniazid twice a week. Methods We did a randomised,
Autor:
Christopher C. Whalen, C R Horsburgh, David L. Hom, Jerrold J. Ellner, Christopher J. Lahart, Michael S. Simberkoff
Publikováno v:
AIDS. 11:455-460
Objective: Infection with HIV adversely affects survival in patients with tuberculosis (TB), even when TB is effectively treated. The aim of this study was to identify the determinants of survival in HIV-associated TB. Design: Retrospective cohort st
Autor:
Nancy G. Klimas, John D. Hamilton, Philip L. Day, Merrill J. Egorin, Susan B. Zolla Pazner, George L. Drusano, Gigi R. Diamond, Charles N. Oster, Clifton A. Hawkes, Ann M. Labriola, Michael S. Simberkoff, Fred M. Gordin, Nelda P. Wray, Peter Jensen, W. Lance George, Kent J. Weinhold, Christopher J. Lahart, G. Dickinson, Pamela M. Hartigan, William A. O'Brien
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 11:142-150
Following a 4-year controlled trial comparing early and later zidovudine treatment, we conducted an additional 3-year follow-up. Of the original 338 patients, 275 participated. Clinical outcome measures were AIDS and death. In the early therapy group
Autor:
Christopher C. Whalen, C R Horsburgh, Michael S. Simberkoff, Christopher J. Lahart, Jerrold J. Ellner, David L. Hom
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 151:129-135
To determine the effect of active tuberculosis on survival and the incidence of opportunistic infections in HIV-infected patients, we performed a retrospective cohort study at four U.S. medical centers to compare the survival and incidence rate of op
Autor:
John D. Hamilton, Pamela M. Hartigan, Michael S. Simberkoff, Philip L. Day, Gigi R. Diamond, Gordon M. Dickinson, George L. Drusano, Merrill J. Egorin, W. Lance George, Fred M. Gordin, Clifton A. Hawkes, Peter C. Jensen, Nancy G. Klimas, Ann M. Labriola, Christopher J. Lahart, William A. O'Brien, Charles N. Oster, Kent J. Weinhold, Nelda P. Wray, Susan B. Zolla-Pazner
Publikováno v:
New England Journal of Medicine. 326:437-443
Background. Zidovudine is recommended for asymptomatic and early symptomatic human immunodeficiency virus (HIV) infection. The best time to initiate zidovudine treatment remains uncertain, however, and whether early treatment improves survival has no
Autor:
Holly H. Birdsall, Rhonda A. Cole, Charlene M. Dewey, Jane M. Geraci, Sheila Goodnight-White, Gabriel B. Habib, Richard J. Hamill, Mary P. Harward, Teresa G. Hayes, Christopher J. Lahart, Martha P. Mims, Sharma S. Prabhakar, Wayne J. Riley, Loren A. Rolak, Roger D. Rossen, Richard A. Rubin, Sarah E. Selleck, Samuel A. Shelburne, Mark M. Udden, Whitney W. Woodmansee, Anthony J. Zollo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f2096508fc8eae581aa7d544e599c54
https://doi.org/10.1016/b978-84-8174-886-4.50019-2
https://doi.org/10.1016/b978-84-8174-886-4.50019-2